KRAS Mutation Is an Important Predictor of Resistance to...

Clinical Cancer Research 2007 / 05 Vol. 13; Iss. 10

KRAS Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer

Massarelli, E., Varella-Garcia, M., Tang, X., Xavier, A. C., Ozburn, N. C., Liu, D. D., Bekele, B. N., Herbst, R. S., Wistuba, I. I.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-06-3043
Date:
May, 2007
File:
PDF, 196 KB
english, 2007
Conversion to is in progress
Conversion to is failed